Revilab Peptide 02

Dosage form Application area Recommendations for use Contraindications Manufacturer
Read on
Certificate number:RU.77.99.88.003.Е.001648.04.17
Date of registration and renewal:05.04.2017
Dosage form: & nbspTablets without an envelope weighing 350 mg, tablets in a water or enteric coating with a mass of 370 mg, capsules of 300 mg.
Classification "Composition" & nbsp Supplements - vitamins, vitamin-like substances and coenzymes
Classification "Clinical" & nbsp BAD-sources of multivitamins without mineral complexes
Composition: & nbspOmega-3 fatty acids, a mixture of tocopherols, AA-3 peptide complex, AA-2 peptide complex, AA-10 peptide complex, pyridoxine hydrochloride, AA-4 peptide complex, folic acid, E460, lactose monohydrate, E470a, E551, water or enteric coating of tablets (E904, E464, E171, E1521), the composition of the capsule shell (gelatin or E464, without addition or addition of food coloring E140, E141, E160a, E162, E163, E171).
Scope: & nbspFor realization to the population as a biologically active additive to food - an additional source of vitamins E, B6, folic acid.
Suggested Usage: & nbspAdults: 1 capsule / 1 tablet daily with meals. Duration of admission 4-6 weeks. If necessary, the reception can be repeated. Repeated receptions are possible throughout the year.
Contraindications:Individual intolerance of components, pregnancy, breast-feeding.
Special instructions:Before use, it is recommended to consult a doctor.
Shelf life:3 years.
Storage conditions:Store in original original packaging in a dry place inaccessible to children, at a temperature not exceeding 25 ° C.
Research protocols:In exchange for the certificate of state registration No. RU.77.99.88.003.E.000507.02.17 of 03.02.2017; expert conclusion of the Federal Antimonopoly Service of the Russian Federation "ФЦГиЭ Роспотребнадзора" №10-2ФЦ / 131 from 19.01.2017.
Recipient:SPC, OOOSPC, OOO Russian Federation
Information update date: & nbsp15.04.2017
Instructions
Up